These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Giant extra-adrenal pheochromocytoma: magnetic resonance imaging with gadolinium-DTPA enhancement. Terk MR; de Verdier H; Colletti PM Magn Reson Imaging; 1993; 11(1):47-50. PubMed ID: 8423721 [TBL] [Abstract][Full Text] [Related]
52. Use of Gd-DTPA and fast gradient-echo and spin-echo MR imaging to demonstrate renal function in the rabbit. Carvlin MJ; Arger PH; Kundel HL; Axel L; Dougherty L; Kassab EA; Moore B Radiology; 1989 Mar; 170(3 Pt 1):705-11. PubMed ID: 2916024 [TBL] [Abstract][Full Text] [Related]
53. Observations of the early diuretic response after intravenous administration of bumetanide and furosemide in dogs. Olsen UB Acta Physiol Scand; 1975 Feb; 93(2):195-201. PubMed ID: 1146571 [TBL] [Abstract][Full Text] [Related]
54. Gadolinium-enhanced liver magnetic resonance imaging using a 2-point Dixon fat-water separation technique: impact upon image quality and lesion detection. Rosenkrantz AB; Mannelli L; Kim S; Babb JS J Comput Assist Tomogr; 2011; 35(1):96-101. PubMed ID: 21160433 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of gadopentetate dimeglumine magnetic resonance cisternography in an animal model: preliminary report. Jinkins JR; Williams RF; Xiong L Invest Radiol; 1999 Feb; 34(2):156-9. PubMed ID: 9951796 [TBL] [Abstract][Full Text] [Related]
56. Gadolinium use in patients with kidney disease: a cause for concern. Perazella MA; Rodby RA Semin Dial; 2007; 20(3):179-85. PubMed ID: 17555477 [TBL] [Abstract][Full Text] [Related]
57. Gadoxetic acid-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase. Torrisi C; Picone D; Cabibbo G; Matranga D; Midiri M; Brancatelli G Eur J Radiol; 2018 Oct; 107():39-45. PubMed ID: 30292271 [TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance imaging of therapy-induced necrosis using gadolinium-chelated polyglutamic acids. Jackson EF; Esparza-Coss E; Wen X; Ng CS; Daniel SL; Price RE; Rivera B; Charnsangavej C; Gelovani JG; Li C Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):830-8. PubMed ID: 17379450 [TBL] [Abstract][Full Text] [Related]
59. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment. Mihara F; Gupta KL; Righi AM Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024 [TBL] [Abstract][Full Text] [Related]
60. Statistical analysis of pharmacokinetic models in dynamic contrast-enhanced magnetic resonance imaging. Schmid VJ; Whitcher BJ; Yang GZ; Taylor NJ; Padhani AR Med Image Comput Comput Assist Interv; 2005; 8(Pt 2):886-93. PubMed ID: 16686044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]